Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia VeraContributed by: Business WireLogoTagsResearchFDAClinical TrialsCardiologyBiotechnologyHealthPharmaceuticalScienceOncologyProtagonist